Robert Smith listens as Dr. Vladimir Berthaud speaks with Black patients about participating in clinical trials for a COVID-19 vaccine candidate./Blake Farmer for KHN
So far, participation by minority volunteers in coronavirus trials has increased only slightly compared with the usually low levels in other clinical trials.
Silver diamine fluoride is a topical medication that gets painted on teeth to stem decay. It could become a game changer for treating cavities in older adults./Jennifer Geiselhofer
Silver diamine fluoride, a liquid that can be painted on teeth to stop decay, is rapidly gaining momentum as the cavity treatment of choice for patients who can’t easily get a filling.
The Food and Drug Administration is weighing whether to resume a coronavirus vaccine trial that was halted when a volunteer suffered spinal cord damage as federal health officials launch an investigation.
Sep 14, 2020
Image
Mardell Reed volunteers for Advocates for African American Elders in Pasadena, California, a group that helps Blacks with health issues.Heidi di Marco/Kaiser Health News
Medical marijuana was legal but not mainstream in 2009 when Tamarack Dispensary opened in Kalispell, Montana. Now it's a normal part of the community./Justin Franz /KHN
The nation's top infectious disease expert says If a monitoring board gave the green light, vaccine manufacturers would be obligated to end their trials early and make the shots available.
If enough of the population gets vaccinated — more than the 45% who did last flu season — it could help head off a nightmare scenario this winter of hospitals stuffed with flu or COVID-19 patients.
Aug 31, 2020
Image
Frank and Leslie Cutitta outside their home in Wayland, Massachusetts./Jesse Costa/WBUR
Doctors studying this phenomenon are concerned that medical teams are not waiting long enough for these patients to wake up.
Aug 27, 2020
Image
Audrey Kuehl, a study coordinator at the Clinical Research Institute of Southern Oregon, inoculates Trish Malone with Moderna’s COVID-19 vaccine.
|
JIM CRAVEN FOR KAISER HEALTH NEWS
The Clinical Research Institute of Southern Oregon in Medford is among 90 sites across the country tapped to test a leading vaccine candidate by Moderna against COVID-19.